1205
Aspirin-Exacerbated Respiratory Disease (AERD): Clinical Science
Friday, February 20, 2015: 9:00 AM-12:00 PM
Convention Center, Level Three, Room 362
3.00 CME/ 3.40 CE
Primary Moderators:
C. J. Corrigan , MD PhD FAAAAI
Marek L. Kowalski , MD PhD

Learning Objectives

  1. Recognize that AERD may be more than one disease
  2. Identify novel therapies of AERD
  3. Describe the genetic and epigenetic causes of AERD
9:00 AM
A Controlled Trial of Aspirin Desensitization in AERD
Marek L. Kowalski, MD PhD
9:25 AM
Identification of a Novel Endophenotype of AERD with Markedly Aberrant Regulation of Prostaglandin D2
Katherine N. Cahill, MD
9:50 AM
New Approaches to the Treatment of AERD: Does a Dietary Intervention Work?
Tanya M. Laidlaw, MD FAAAAI
10:15 AM
Question & Answer
10:25 AM
Break
10:35 AM
The Efficacy of Anti-IgE as a Therapy for AERD
Masami Taniguchi, MD PhD
11:00 AM
Studies of LTE4 and COX-2 in Aspirin-Tolerant and Intolerant Asthma
Barbro Dahlen, MD PhD
11:25 AM
Respiratory Reactions to Alcohol in AERD
Andrew A. White, MD FAAAAI
11:50 AM
Question & Answer
See more of: Course